Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Recruiting 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 2 Stomach Neoplasms 1 Postoperative Complications 1 Pain 1 Motor Activity 1 Lung Neoplasms 1 Frailty 1 Disease 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Trastuzumab 16 pertuzumab 14 Capecitabine 14 Docetaxel 12 pyrotinib 11 Cyclophosphamide 11 Standard of Care 10 Paclitaxel 10 Letrozole 10 trastuzumab deruxtecan 9 Radiotherapy 9 Carboplatin 9 Fulvestrant 8 Drug Therapy 8 sacituzumab govitecan 7 dalpiciclib 7 exemestane 6 eribulin 6 Tamoxifen 6 Epirubicin 6 Anastrozole 6 pembrolizumab 5 palbociclib 5 abemaciclib 5 Surveys and Questionnaires 5 Neoadjuvant Therapy 5 Aromatase Inhibitors 5 camrelizumab 4 Sentinel Lymph Node Biopsy 4 Doxorubicin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Breast Neoplasms × Preoperative Exercise × Clear all

NCT07418060 2026-06-04

PREHAB KINELGD

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡